Bora Pharmaceuticals USA Inc. announced that it will receive $57,000,000 in an equity round of funding on May 14, 2024. The transaction include the participation from returning investor, Bora Pharmaceuticals Co., LTD., hold 100% stake in the company. The transaction has been approved by the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
764 TWD | +4.66% | +1.60% | +19.56% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.56% | 236.77Cr | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr | |
-0.45% | 16TCr |
- Stock Market
- Equities
- 6472 Stock
- News Bora Pharmaceuticals Co., LTD.
- Bora Pharmaceuticals USA Inc. announced that it expects to receive $57 million in funding from Bora Pharmaceuticals Co., LTD.